Iradokizunak:
"past studies focusing" » "post studies focusing" (Hedatu), "part studies focusing" (Hedatu), "last studies focusing" (Hedatu)
Erakusten 1 - 11 emaitzak -- 11 bilaketa honetara '"past studies focusing"', Bilaketaren denbora: 0,02s Findu emaitzak
  1. 1
    Multivariate analysis between DENV and CHIKV seroconversion and selected risk factors.

    Multivariate analysis between DENV and CHIKV seroconversion and selected risk factors. nork Bethel Alebel Bayrau (22676588)

    Argitaratua 2025
    Gaiak:
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Seroprevalence of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022.

    Seroprevalence of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. nork Bethel Alebel Bayrau (22676588)

    Argitaratua 2025
    Gaiak:
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Descriptive statistics and demographics of study participants, Ukunda and Kisumu sites, Kenya, Dec 2019–Feb 2022.

    Descriptive statistics and demographics of study participants, Ukunda and Kisumu sites, Kenya, Dec 2019–Feb 2022. nork Bethel Alebel Bayrau (22676588)

    Argitaratua 2025
    Gaiak:
    Gogokoenen artean sartu
    Gorde:
  4. 4
    DENV and CHIKV IgG serology and RT-PCR test results among overall study population and individual study sites Ukunda and Kisumu, Kenya, Dec 2019–Feb 2022.

    DENV and CHIKV IgG serology and RT-PCR test results among overall study population and individual study sites Ukunda and Kisumu, Kenya, Dec 2019–Feb 2022. nork Bethel Alebel Bayrau (22676588)

    Argitaratua 2025
    Gaiak:
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Univariate analysis between DENV and CHIKV seropositivity and selected risk factors.

    Univariate analysis between DENV and CHIKV seropositivity and selected risk factors. nork Bethel Alebel Bayrau (22676588)

    Argitaratua 2025
    Gaiak:
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Seroconversion of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022.

    Seroconversion of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. nork Bethel Alebel Bayrau (22676588)

    Argitaratua 2025
    Gaiak:
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Kaplan Meier survival curves for new CHIKV seropositivity during the 2- year study period from Dec 2019 – Feb 2022.

    Kaplan Meier survival curves for new CHIKV seropositivity during the 2- year study period from Dec 2019 – Feb 2022. nork Bethel Alebel Bayrau (22676588)

    Argitaratua 2025
    Gaiak:
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Kaplan Meier survival curves for new DENV seropositivity during the 2-year study period from Dec 2019 – Feb 2022..

    Kaplan Meier survival curves for new DENV seropositivity during the 2-year study period from Dec 2019 – Feb 2022.. nork Bethel Alebel Bayrau (22676588)

    Argitaratua 2025
    Gaiak:
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Multivariate analysis between DENV and CHIKV seropositivity and selected risk factors.

    Multivariate analysis between DENV and CHIKV seropositivity and selected risk factors. nork Bethel Alebel Bayrau (22676588)

    Argitaratua 2025
    Gaiak:
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Univariate analysis between DENV and CHIKV seroconversion and selected risk factors.

    Univariate analysis between DENV and CHIKV seroconversion and selected risk factors. nork Bethel Alebel Bayrau (22676588)

    Argitaratua 2025
    Gaiak:
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Distribution of DENV and CHIKV seroprevalence by age group of participants in the study.

    Distribution of DENV and CHIKV seroprevalence by age group of participants in the study. nork Bethel Alebel Bayrau (22676588)

    Argitaratua 2025
    Gaiak:
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: